Umoja wa Ulaya - Kifinlandi - EMA (European Medicines Agency)

accord healthcare s.l.u. - teriparatidi - osteoporoosi - kalsiumin homeostaasi - sondelbay is indicated in adults. osteoporoosin hoito postmenopausaalisilla naisilla ja miehillä, joilla on lisääntynyt murtumisriski. in postmenopausal women, a significant reduction in the incidence of vertebral and non-vertebral fractures but not hip fractures have been demonstrated. hoito osteoporoosi liittyy pitkäaikaiseen, systeemiseen glukokortikoidihoitoon naisilla ja miehillä on suurempi riski saada murtuma.

Umoja wa Ulaya - Kifinlandi - EMA (European Medicines Agency)

aop orphan pharmaceuticals gmbh - sugammadex sodium - neuromuskulaarinen estäminen - kaikki muut terapeuttiset tuotteet - neuromuskulaarisen salpauksen aiheuttama rokuronin tai vekuronin. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.

Umoja wa Ulaya - Kifinlandi - EMA (European Medicines Agency)

sun pharmaceutical industries europe b.v. - teriparatidi - osteoporosis; osteoporosis, postmenopausal - kalsiumin homeostaasi - teriparatide sun is indicated in adults. treatment of osteoporosis in postmenopausal women and in men at increased risk of fracture (see section 5. in postmenopausal women, a significant reduction in the incidence of vertebral and non-vertebral fractures but not hip fractures has been demonstrated. treatment of osteoporosis associated with sustained systemic glucocorticoid therapy in women and men at increased risk for fracture (see section 5.

Umoja wa Ulaya - Kifinlandi - EMA (European Medicines Agency)

strides pharma (cyprus) limited - teriparatidi - osteoporosis; osteoporosis, postmenopausal - kalsiumin homeostaasi - kauliv is indicated in adults. treatment of osteoporosis in postmenopausal women and in men at increased risk of fracture (see section 5. in postmenopausal women, a significant reduction in the incidence of vertebral and non-vertebral fractures but not hip fractures has been demonstrated. treatment of osteoporosis associated with sustained systemic glucocorticoid therapy in women and men at increased risk for fracture (see section 5.

Umoja wa Ulaya - Kifinlandi - EMA (European Medicines Agency)

piramal critical care b.v. - sugammadex sodium - neuromuskulaarinen estäminen - sugammadeksi - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults.

Umoja wa Ulaya - Kifinlandi - EMA (European Medicines Agency)

extrovis eu ltd. - sugammadex sodium - neuromuskulaarinen estäminen - kaikki muut terapeuttiset tuotteet - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.

Umoja wa Ulaya - Kifinlandi - EMA (European Medicines Agency)

stemline therapeutics b.v. - elacestrant - rintojen kasvaimet - endokriinihoito - orserdu monotherapy is indicated for the treatment of postmenopausal women, and men, with estrogen receptor (er) positive, her2-negative, locally advanced or metastatic breast cancer with an activating esr1 mutation who have disease progression following at least one line of endocrine therapy including a cdk 4/6 inhibitor.

Umoja wa Ulaya - Kifinlandi - EMA (European Medicines Agency)

ferring pharmaceuticals a/s - degareliksia - prostatiset kasvaimet - endokriinihoito - firmagon is a gonadotrophin releasing hormone (gnrh) antagonist indicated:- for treatment of adult male patients with advanced hormone-dependent prostate cancer. - for treatment of high-risk localised and locally advanced hormone dependent prostate cancer in combination with radiotherapy. - as neo-adjuvant treatment prior to radiotherapy in patients with high-risk localised or locally advanced hormone dependent prostate cancer.

Umoja wa Ulaya - Kifinlandi - EMA (European Medicines Agency)

zoetis belgium sa - oklacitinibimaleaattia - dermatiittiautia lukuun ottamatta kortikosteroideja - koirat - - treatment of pruritus associated with allergic dermatitis in dogs. - treatment of clinical manifestations of atopic dermatitis in dogs.

Umoja wa Ulaya - Kifinlandi - EMA (European Medicines Agency)

ceva santé animale - benazepril hydrochloride, spironolactone - sydÄn-jÄrjestelmÄ - koirat - koirille kroonisen degeneratiivisen valssaan sairauden aiheuttama kongestiivisen sydämen vajaatoiminnan hoito (tarvittaessa diureettinen tuki).